Back to search

Article

Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecoviruses

2022-01-26

Abstract excerpt

As the SARS-CoV-2 pandemic enters its third year, vaccines that not only prevent disease, but also prevent transmission are needed to help reduce global disease burden. Currently approved parenteral vaccines induce robust systemic immunity, but poor immunity at the respiratory mucosa. Here we describe the development of a novel vaccine strategy, Prime and Spike, based on unadjuvanted intranasal spike boosting that...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
52b9fd7c-1f62-5231-ad3d-bf1c82a4554b
DOI
10.1101/2022.01.24.477597
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecovirusesDOI 10.1101/2022.01.24.477597
Select a neighboring publication to make it the new centre.